KRIBIOLISA™ Panitumumab (VECTIBIX) ELISA
KRISHGEN BioSystemsThe Palivizumab ELISA kit is intended for the quantitative determination of Palivizumab in serum, plasma and cell culture samples.
The Palivizumab ELISA kit is intended for the quantitative determination of Palivizumab in serum, plasma and cell culture samples.
Find out what the experts really think
Prepare Cap 1-RNA from any source of Cap 0-RNA. Use simultaneously with ScriptCap™ m7G Capping System to produce virtually 100% Cap 1-capped RNA in a single reaction.
The InterPlay TAP Purification Buffer Kit is designed to work with the InterPlay Mammalian TAP System and InterPlay Adenoviral TAP System to recover interacting proteins from mammalian cells. The InterPlay TAP Purification Buffer Kit includes the buffers required to perform tandem affinity purification.
Tyrosine kinase inhibitor; Inhibits EGFR, HER2, JAK2, JAK3 and STAT5a/b
AMPK activator; Mitochondrial respiratory chain complex 1 inhibitor
Expert Biomarker Discovery Services using cutting-edge technologies such as high-quality proteomics with Proximity Extension Assay (PEA) technology from Olink, and ultra-sensitive detection with proven Simoa technology. We offer ideal broad screening-to-targeted biomarker discovery solutions in different therapeutic areas.
Discover how the Department of Clinical Immunology and Biochemistry at Vejle Hospital is improving diagnostics & patient care using liquid chromatography
New platform adds seamless link to compound structure assessment in 3D docking and alignment models
An introduction to the challenges and considerations for clinical labs embarking on digital transformation in healthcare
Novel findings are a promising step in the development of new tests for cancer diagnostics
The RACE act has led to increased requirements for approval of recent pediatric cancer drugs
Mark Hegarty, CEO of Dxcover, reveals how infrared spectroscopy coupled with machine learning could transform the future of cancer diagnosis
Diadem announces publication of clinical data showing its AlzoSure biomarker test is able to predict progression to Alzheimer’s disease years before symptoms are displayed.